Physician

Muhammad Mansoor Alam, M.D

According to 2025 Medicare claims, Muhammad Alam, M.D (NPI: 1417906835) practices hematology/oncology in the Fresno, CA market, with the plurality of this provider's patient population coming from Fresno, CA. This provider's primary affiliated billing organization is PREMIER CANCER CARE AND INFUSION CENTER (NPI: 1568190064; TIN: 882272893) and primary practice location at 93710-9998.

Alam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 480 traditional Medicare patients, billed 66,943 HCPCS/CPT codes, and received $1,118,792 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,345 prescription claims across 255 beneficiaries totaling $2,986,066 in drug costs, led by Zejula (Niraparib Tosylate). DME data shows 12 claims. Open Payments data shows 183 records totaling $5,067. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $112,368 to $1,118,792. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $948,810 to $2,986,066. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $11,026 to $8,560.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$559K$1.1M2015 Medicare payment: $112,368 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $116,581 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $76,469 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $107,392 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $239,794 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $167,240 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $179,314 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $230,802 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $204,166 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,118,792 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152034,700$112,368
201624526,430$116,581
2017196744$76,469
20182731,201$107,392
20194352,928$239,794
20204752,500$167,240
20214762,074$179,314
20225702,836$230,802
20235632,704$204,166
202448066,943$1,118,792

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.8M$3.6M2015 Drug cost: $948,810 (USD; Tot_Drug_Cst)2016 Drug cost: $690,650 (USD; Tot_Drug_Cst)2017 Drug cost: $321,242 (USD; Tot_Drug_Cst)2018 Drug cost: $740,474 (USD; Tot_Drug_Cst)2019 Drug cost: $1,449,724 (USD; Tot_Drug_Cst)2020 Drug cost: $2,379,342 (USD; Tot_Drug_Cst)2021 Drug cost: $3,084,415 (USD; Tot_Drug_Cst)2022 Drug cost: $3,579,661 (USD; Tot_Drug_Cst)2023 Drug cost: $3,149,595 (USD; Tot_Drug_Cst)2024 Drug cost: $2,986,066 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151681,279$948,810
2016155913$690,650
2017117658$321,242
20181431,191$740,474
20191971,828$1,449,724
20202501,998$2,379,342
20212762,445$3,084,415
20223122,911$3,579,661
20232982,163$3,149,595
20242551,345$2,986,066

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$57K$114K2015 Medicare payment: $11,026 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,426 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $4,915 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $114,038 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $27,988 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $184 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R91$11,026
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R52$3,426
2021N/R119$4,915
2022N/R286$114,038
202311126$27,988
2024N/R12$184

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more123276$139
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes101117$137
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more9191$133
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more249572$97
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes91437$94

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ZejulaNiraparib Tosylate24720$673,802
RevlimidLenalidomide13350$225,967
WeliregBelzutifan12360$225,070
XtandiEnzalutamide18540$206,502
SprycelDasatinib11330$193,119

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R12$184

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.183$5,067AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Muhammad Mansoor Alam, M.D?

Tedicare shows public-source Medicare data for Muhammad Mansoor Alam, M.D (NPI 1417906835), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Muhammad Mansoor Alam, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Muhammad Mansoor Alam, M.D?

Muhammad Mansoor Alam, M.D is linked to PREMIER CANCER CARE AND INFUSION CENTER (billing NPI 1568190064) in the available physician profile data.

Does Muhammad Mansoor Alam, M.D have Open Payments data?

Muhammad Mansoor Alam, M.D has 183 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.